Identification and characterization of Rhipicephalus (Boophilus) microplus candidate protective antigens for the control of cattle tick infestations by Almazán, Consuelo et al.
ORIGINAL PAPER
Identification and characterization of Rhipicephalus (Boophilus)
microplus candidate protective antigens for the control
of cattle tick infestations
Consuelo Almazán & Rodolfo Lagunes & Margarita Villar & Mario Canales &
Rodrigo Rosario-Cruz & Frans Jongejan & José de la Fuente
Received: 11 August 2009 /Accepted: 10 November 2009 /Published online: 27 November 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract The cattle ticks, Rhipicephalus (Boophilus) spp.,
affect cattle production in tropical and subtropical regions
of the world. Tick vaccines constitute a cost-effective and
environmentally friendly alternative to tick control. The
recombinant Rhipicephalus microplus Bm86 antigen has
been shown to protect cattle against tick infestations.
However, variable efficacy of Bm86-based vaccines against
geographic tick strains has encouraged the research for
additional tick-protective antigens. Herein, we describe the
analysis of R. microplus glutathione-S transferase, ubiquitin
(UBQ), selenoprotein W, elongation factor-1 alpha, and
subolesin (SUB) complementary DNAs (cDNAs) by RNA
interference (RNAi) in R. microplus and Rhipicephalus
annulatus. Candidate protective antigens were selected for
vaccination experiments based on the effect of gene
knockdown on tick mortality, feeding, and fertility. Two
cDNA clones encoding for UBQ and SUB were used for
cattle vaccination and infestation with R. microplus and
R. annulatus. Control groups were immunized with
recombinant Bm86 or adjuvant/saline. The highest vaccine
efficacy for the control of tick infestations was obtained for
Bm86. Although with low immunogenic response, the
results with the SUB vaccine encourage further investiga-
tions on the use of recombinant subolesin alone or in
combination with other antigens for the control of cattle
tick infestations. The UBQ peptide showed low immuno-
genicity, and the results of the vaccination trial were
inconclusive to assess the protective efficacy of this
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DOI 10.1007/s00436-009-1689-1antigen. These experiments showed that RNAi could be
used for the selection of candidate tick-protective antigens.
However, vaccination trials are necessary to evaluate the
effect of recombinant antigens in the control of tick
infestations, a process that requires efficient recombinant
protein production and formulation systems.
Introduction
Rhipicephalus (Boophilus) spp. ticks are distributed in
tropical and subtropical regions of the world with range
expansion for some species due to changes in climatic
conditions (Barker and Murrell 2004; Estrada-Peña et al.
2006; Olwoch et al. 2007). Infestations with the cattle tick,
Rhipicephalus microplus, economically impact cattle pro-
duction by reducing weight gain and milk production, and
by transmitting pathogens that cause babesiosis (Babesia
bovis and Babesia bigemina) and anaplasmosis (Anaplasma
marginale; Peter et al. 2005). Rhipicephalus annulatus is
present in regions of Asia, Latin America, and Africa
(Estrada-Peña et al. 2006) where it may also affect cattle
production and transmit pathogens.
Acaricide application constitutes a major component of
integrated tick control strategies (Graf et al. 2004).
However, use of acaricides has had limited efficacy in
reducing tick infestations and is often accompanied by
serious drawbacks, including the selection of acaricide-
resistant ticks, environmental contamination, and contami-
nation of milk and meat products with drug residues (Graf
et al. 2004). All of these issues reinforce the need for
alternative approaches to control tick infestations such as
the use of hosts with natural resistance to ticks, pheromone-
impregnated decoys for attracting and killing ticks, biolog-
ical control agents, and vaccines (de la Fuente and Kocan
2006; Sonenshine et al. 2006; Willadsen 2006).
In the early 1990s, vaccines inducing immunological
protection on vertebrate hosts against tick infestations were
developed and commercialized. The commercial vaccines,
Gavac and TickGARD, contained the recombinant
R. microplus Bm86 gut antigen (Willadsen et al. 1989;
Rand et al. 1989; Rodríguez et al. 1994; de la Fuente and
Kocan 2003; de la Fuente et al. 2007a). These vaccines
reduce the number of engorging female ticks, their weight,
and reproductive capacity. Thus, the greatest vaccine effect
was the reduction of larval infestations in subsequent
generations. Vaccine-controlled field trials in combination
with acaricide treatments demonstrated that an integrated
approach resulted in control of tick infestations while
reducing the use of acaricides (de la Fuente et al. 1998,
2007a;d el aF u e n t ea n dK o c a n2003). These trials
demonstrated that control of ticks by vaccination has the
advantages of being cost-effective, reducing environmental
contamination, and preventing the selection of drug
resistant ticks that result from repeated acaricide applica-
tion. In addition, these vaccines may also prevent or reduce
transmission of pathogens by reducing tick populations
and/or affecting tick vector capacity (de la Fuente et al.
1998, 2007a; Rodríguez Valle et al. 2004).
Controlled immunization trials have shown that R. microplus
Bm86-containing vaccines also protect against related tick
species, R. annulatus and Rhipicephalus decoloratus
(Fragoso et al. 1998;d el aF u e n t ee ta l .2000a;d eV o se t
al. 2001). However, R. microplus strain-to-strain variations
in the susceptibility to Bm86 vaccination have been
reported, and the efficacy of the Bm86 vaccine is higher
against R. annulatus than against R. microplus strains,
suggesting that tick genetic and/or physiological differ-
ences may affect the efficacy of tick vaccines in different
regions (Fragoso et al. 1998; García-García et al. 1999;
2000;d el aF u e n t ee ta l .1999, 2000a, b; de Vos et al.
2001;d el aF u e n t ea n dK o c a n2006;S o s s a ie ta l .2005;
Canales et al. 2009a). These results together with the need
to improve vaccine efficacy have encouraged research for
additional tick protective antigens for the control of cattle
t i c ki n f e s t a t i o n s( d el aF u e n t ea n dK o c a n2003, 2006;
Sonenshine et al. 2006; Willadsen 2006).
In the experiments reported herein, selected R. microplus
complementary DNA (cDNA) sequences were character-
ized by RNA interference (RNAi) in unfed and replete adult
ticks. Tick subolesin and ubiquitin were used for vaccina-
tion trials with recombinant proteins in cattle to evaluate
their capacity to protect against cattle tick infestations.
Materials and methods
Tick strains The R. microplus (susceptible Media Joya
strain, CENAPA, Mexico) and R. annulatus (Mercedes
strain, Texas, USA) ticks were obtained from laboratory
colonies maintained at the University of Tamaulipas,
Mexico. Originally, these tick strains were collected from
infested cattle in Tapalpa, Jalisco, Mexico and Mercedes
County, Texas, USA for R. microplus and R. annulatus,
respectively. Tick larvae were fed on cattle and collected
after repletion to allow for oviposition and hatching in
humidity chambers at 12 h light:12 h dark photoperiod, 22–
25°C, and 95% relative humidity (RH). Larvae were
15 days old at the time of infestations.
RNA interference in ticks Genes for RNAi were selected
based on previous results in R. microplus or Dermacentor
variabilis demonstrating the effect of gene knockdown on
tick attachment, mortality, and/or fertility (de la Fuente et
al. 2007b; 2008). These genes included those encoding for
putative glutathione-S transferase (GST; GenBank acces-
472 Parasitol Res (2010) 106:471–479sion number AF077609), ubiquitin (UBQ; AA257892),
selenoprotein W (SEL; tentative consensus sequence
TC19044, http://compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/
tc_report.pl?gudb=b_microplus&tc=TC19044), elongation
factor-1 alpha (EF-1a; EU436163), and subolesin (SUB;
DQ159966).
Oligonucleotide primers containing T7 promoter se-
quences at the 5′-end (GST: GSTBMT75: 5′- TAATACG
ACTCACTATAGGGTACTCCATGGCTCCTGTGCTC
GGCT-3′ and GSTBMT73: 5′- TAATACGACTCACTATA
GGGTACTCATTGAGAGGCCACTTAATGC-3′;U B Q :
UB2BMT75: 5′-TAATACGACTCACTATAGGGTACT
TTGGTCCTGCGGCTCCGCGGAG-3′ and UB2BMT73:
5′-TAATACGACTCACTATAGGGTACTGCCACCACGG
AGCCGCAGGACA-3′; SEL: SEBMT75: 5’-TAATAC
GACTCACTATAGGGTACTCCACCGTGACTGGCACAG
TAG-3′ and SEBMT73: 5′-TAATACGACTCACTATAGGG
TACTCCATACATGAATGGCTTTCCA-3′;E F - 1 a :G I I 5 :
5´-TAATACGACTCACTATAGGGTACTGGCCCACGGAC
AAACCCCTC-3′ and GII3: 5′-TAATACGACTCACTATAG
GGTACTCGACCGTTTGCCTCATGTC-3′;S U B :
D8BMT75: 5′-TAATACGACTCACTATAGGGTACTGACT
GGGACCCCTTGCACAGT-3′ and D8BMT73 5′-TAATAC
GACTCACTATAGGGTACTCGAGTTTGGTAGATAG
CACA-3) were synthesized and used for in vitro transcrip-
tion of double-stranded RNA (dsRNA) using the Access
reverse transcription–polymerase chain reaction (RT–PCR)
system (Promega, Madison, WI, USA) and the Megascript
RNAi kit (Ambion, Austin, TX, USA) following manufac-
turer's instructions. The dsRNA was purified and quantified
by spectrophotometry.
Newly molted R. microplus and R. annulatus females
were injected with approximately 0.3 µl of dsRNA (5×10
10
molecules per microliter) in the lower right quadrant of the
ventral surface of the exoskeleton of the tick (Nijhof et al.
2007). Thirty ticks per group were injected using a
Hamilton syringe with a 1-inch, 33-gauge needle. Control
ticks were injected with the unrelated GIII dsRNA or were
left uninjected. The GIII sequence was identified in
R. microplus and did not affect tick feeding, mortality,
and oviposition after RNAi (unpublished results). Ticks
were held in a humidity chamber for 3–5 h before surviving
ticks were allowed to feed in separate patches, each one for
a different group, glued on the back of a calf. Ten males
were placed in each patch simultaneously with injected
females. Unattached ticks were removed 2 days after
infestation, and attached ticks were allowed to feed until
repletion. Engorged female ticks started to drop off the host
after 8 days and were collected during 4 days. All the
females completing feeding were counted and weighted.
The average ± standard deviation (SD) weights of engorged
females were compared between test and control groups by
Student's t test (P=0.05). Tick attachment was recorded
with respect to surviving ticks after injection, and tick
mortality was recorded with respect to the total number of
attached ticks feeding on the animal and were compared
between test and control groups by χ
2 test (α=0.01). For
oviposition, individual ticks were held in a humidity
chamber at 22–25°C and 95% RH, and the egg mass
oviposited by each tick was weighted and compared between
test and control groups by Student's t test (P=0.05).
Engorged R. microplus and R. annulatus females were
weighted and injected with 5 µl of dsRNA (5×10
10
molecules per microliter) in the right spiracular plate within
6 h after dropping off the host using the same methods as
described above or left uninjected. They were stored
individually in an incubator at 22–25°C and 80% RH. Tick
weight and egg masses removed after oviposition and
weighted were analyzed as described above. Egg batches
were stored separately under the same conditions to
estimate percent hatching by counting the number un-
hatched eggs that was compared between test and control
groups by χ
2 test (α=0.01).
Ten ticks per group were dissected after oviposition and
pooled for RNA extraction to evaluate gene expression by
semiquantitative RT–PCR using the same oligonucleotide
primers used for dsRNA synthesis. The messenger RNA
(mRNA) levels (nanograms per amplicon) were estimated
in ethidium bromide-stained agarose gels by comparison to
a standard curve of the target gene and compared between
target gene dsRNA and GIII dsRNA-injected control ticks
to calculate the percent of gene silencing after RNAi.
Vaccine formulations R. microplus UBQ and SUB were
produced for vaccination trials. Recombinant SUB was
expressed in Escherichia coli from a synthetic gene
(GenBank accession number GQ456170) optimized for
codon usage in E. coli and purified by Ni affinity
chromatography (Genscript Corporation, Piscatway, NJ,
USA; www.genscript.com). The UBQ peptide NH2-
YNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEV
EPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLED was
synthesized and purified at the Bioanalytics, Pharmacology,
and Proteomics facility (Barcelona Biomedical Research
Park, Spain). The recombinant Bm86 (susceptible strain)
used as positive control was secreted in Pichia pastoris and
purified as reported previously (Canales et al. 2008).
Protein adjuvation was made by mixing a solution of
anhydromannitoletheroctodecenoate (Montanide ISA 50 V;
Seppic, Paris, France) with the recombinant protein
solution in batch-by-batch processes using a high-speed
mixer Heidolph DIAX 900 (Heidolph Elektro, Kelheim,
Germany) at 8,000 rpm, and the vaccine was filled
manually under sterile conditions in glass bottles of 20 ml
(Wheaton, Millville, NJ, USA) at a concentration of
100 µg/2 ml dose. Quality controls were made by testing
Parasitol Res (2010) 106:471–479 473mechanical and thermal stability of vaccine emulsions as
described previously (Canales et al. 1997).
Cattle immunization with recombinant proteins and tick
infestations Four 1-year-old European crossbred calves per
group were each immunized with three doses (weeks 1, 4,
and 6) containing 100 µg per dose of purified recombinant
proteins formulated as described above. Negative controls
were injected with adjuvant/saline alone. Cattle were
injected intramuscularly with 2 ml/dose using a 5-ml
syringe and an 18-gauge needle. Two weeks after the last
immunization, cattle in vaccinated and control groups were
infested with 10,000 R. annulatus (Mercedes, Texas, USA
strain) and R. microplus (susceptible, Mexico strain) larvae/
animal applied individually to each animal in separate
cotton cells attached to the back of the animals. Cattle were
cared for in accordance with standards specified in the
Guide for Care and Use of Laboratory Animals.
Data collection and evaluation Adult engorged female
ticks dropping from cattle were daily collected, counted,
and weighted. All the collected adult female ticks were
assessed for oviposition and egg fertility (de la Fuente et al.
1999). The personnel collecting the ticks were “blinded” as
to which group animals belonged. The efficacy of vaccine
formulations was evaluated employing the following
formulae (de la Fuente et al. 1999; Canales et al. 2009a).
Effect on the number of adult female ticks DT ðÞ ¼
100 l   NTV=NTC ðÞ ½  , where NTV is the number of adult
female ticks in the vaccinated group, and NTC is the
number of adult female ticks in the control group.
Effect on tick weight DW ðÞ ¼ 100 1   WTV=WTC ðÞ ½  ,
where WTV is the average adult female tick weight in the
vaccinated group, and WTC is the average adult female tick
weight in the control group.
Effect on oviposition DO ðÞ ¼ 100 1   PATV=PATC ðÞ ½  ,
where PATV is the average weight of the eggs per survived
tick in the vaccinated group, and PATC is the average
weight of the eggs per survived tick in the control group.
Effect on egg fertility DF ðÞ ¼ 100 1   PPLOV= ð ½
PPLOCÞ , where PPLOV is the average weight of the
larvae per gram of eggs in the vaccinated group, and
PPLOC is the average weight of the larvae per gram of eggs
in the control group.
Vaccine efficacy (E) was calculated as 100 l   CRT  ð ½
CR0   CRFÞ , where CRT=NTV/NTC, CR0=PATV/
PATC, and CRF=PPLOV/PPLOC that represent the reduc-
tion in the number of adult female ticks, oviposition, and
egg fertility as compared to the control group, respectively.
A Student's t test with unequal variance (P=0.05) was
used to compare the results of adult female tick number,
tick weight, oviposition, and egg fertility between vaccinated
and control groups.
Determination of serum antibody levels by enzyme-linked
immunosorbent assay Before each immunization and
21 days after the last immunization, blood samples were
collected from each calf into sterile tubes and maintained at
4°C until arrival at the laboratory. Serum was then
separated after centrifugation and stored at −20°C. Serum
antibody titers were determined using an antigen-specific
indirect enzyme-linked immunosorbent assay (ELISA).
Purified UBQ, SUB, and Bm86 (susceptible strain)
antigens (0.1 µg per well) were used to coat ELISA plates
overnight at 4°C. Sera were serially diluted to 1:10, 1:100,
and 1:1,000 in phosphate-buffered saline with Tween 20
(PBST; PBS/0.5% Tween 20, pH 7.2) and 10% fetal bovine
serum (Sigma). The plates were incubated with the diluted
sera for 1 h at 37°C and then incubated with 1:10,000 rabbit
antibovine immunoglubolinG (IgG)–horseradish peroxidase
conjugates (Sigma) for 1 h at 37°C. The color reaction was
developed with 3,3′,5,5′- tetramethylbenzidine (Sigma), and
the optical density450 nm (OD) was determined. After
incubation, the plates were washed with PBST. Antibody
titers were considered positive when they yielded an
OD450 nm value at least twice as high as the preimmune
serum. Antibody titers in immunized cattle were expressed
as the OD450 nm value for the highest serum dilution
(1:1,000) and compared between vaccinated and control
cattle using an analysis of variance (ANOVA) test (P<
0.05). Correlation analyses were conducted in Microsoft
Excel to compare antibody titers at the time of tick
infestation and vaccine efficacy calculated in individual
cattle.
Results and discussion
The discovery and characterization of new tick-protective
antigens is important to improve existing vaccines for the
control of cattle tick infestations (de la Fuente et al. 2007a).
However, the expenses and difficulties associated with the
screening of tick-protective antigens and cattle vaccination
trials constitute an obstacle toward this goal. Recently, RNAi
has been proposed as a method for the rapid screening of
tick-protective antigens (de la Fuente et al. 2005, 2007c).
However, vaccination trials are ultimately needed to charac-
terize new candidate tick-protective antigens.
In these experiments, RNAi was used to select the
antigens for vaccination trials based on the effect of gene
knockdown on cattle tick mortality, feeding, and fertility.
The GST, UBQ, SEL, EF-1a, and SUB genes were selected
for RNAi experiments in R. annulatus and/or R. microplus
based on previous results in R. microplus or D. variabilis
demonstrating an effect of gene knockdown on tick
attachment, mortality, and/or fertility (de la Fuente et al.
2007b, 2008). The results showed that GST and SEL gene
474 Parasitol Res (2010) 106:471–479knockdown affected tick attachment (60% and 65% tick
attachment, respectively, when compared to 91% attach-
ment in the controls; α<0.01) as in previous experiments
with D. variabilis (de la Fuente et al. 2007b) but had no
effect on R. microplus mortality and oviposition (Table 1)
and were not characterized further. As in previous experi-
ments (de la Fuente et al. 2007b, 2008), RNAi with UBQ,
EF-1a, and SUB increased R. microplus mortality and
reduced oviposition when compared to controls (Table 1).
Despite the fact that gene expression was silenced between
75% and 100% in target gene dsRNA-injected R. microplus
and R. annulatus ticks when compared to controls, in
R. annulatus, only EF-1a knockdown had an effect on both
tick mortality and oviposition (Table 2). However, tick-to-
tick variations in RNAi results were higher in R. annulatus
than in R. microplus probably because RNAi conditions are
better established for R. microplus (Nijhof et al. 2007).
R. microplus UBQ, SUB, and EF-1a were selected for
vaccination trials based on their effect on tick mortality and/
or oviposition after RNAi (Tables 1 and 2). However,
recombinant EF-1a could not be produced in sufficient
quantities for protein purification and vaccination trials
were conducted with recombinant UBQ and SUB only in
comparison with Bm86 (positive control) and adjuvant/
saline (negative control).
Except for cattle immunized with recombinant SUB,
antibody titers in vaccinated cattle increased after succes-
sive immunizations (Fig. 1). However, anti-UBQ antibody
titers in immunized cattle were not significantly different
from control animals (Fig. 1). The poor immunogenicity of
the UBQ vaccine could reflect self-tolerance to a highly
conserved molecule in eukaryotes and the fact that short
peptides are often not immunogenic and require conjuga-
tion to a carrier protein or the use of potent adjuvants to
Table 1 Summary of RNAi experiments in unfed and engorged R. microplus female ticks
Parameter R. microplus cDNA group
GST UBQ SEL SUB EF-1a GIII UNI
Unfed female R. microplus
Tick mortality (%) 43 77* 50 73* 77* 53 27
ND 70* 53 67* 73* 53 ND
Tick weight (mg) 214±115** 85±129*** 211±124** 8±2*** 55±140*** 307±125 485±113
ND 227±95 191±130** 7±3*** 4±5*** 292±125 ND
Eggs/tick (mg) 80±60 0±0*** 59±64 8±2** 22±58 26±39 103±64
ND 0±0*** 121±43 0±0*** 0±0*** 61±51 ND
Engorged female R. microplus
Tick weight (mg) 301±67 314±18 302±47 284±45 324±39 364±22 288±72
Eggs/tick (mg) 151±34 89±30*** 109±14** 101±83 123±89 191±10 158±46
Egg hatching (%) 70 30* 30* 10* 5* 70 80
Adult ticks (N=30 for unfed and N=3 for engorged females) were injected with dsRNA or left uninjected (UNI). Two experiments were
conducted in unfed ticks while a single experiment was done with engorged female ticks. Tick mortality and egg hatching are shown in percent
and were compared to the GIII dsRNA-injected control ticks by χ2 test (*α<0.01). Tick weight and oviposition (eggs per tick) are shown as
average ± SD and were compared to the GIII dsRNA-injected control ticks by Student's t test (**P<0.05; ***P<0.01)
ND not done, UNI uninjected
Table 2 Summary of RNAi experiments in unfed R. annulatus female ticks
Parameter R. microplus cDNA group
UBQ SUB EF-1a GIII UNI
Tick mortality (%) 63* 47 90* 47 53
Tick weigh (mg) 235±113 69±86*** 25±22*** 206±108 199±128
Eggs/tick (mg) 97±70 70±83 0±0*** 114±56 116±71
Hatching (%) 80 20* 0* 100 90
Adult unfed female ticks (N=30) were injected with dsRNA or left uninjected (UNI). Tick mortality and egg hatching are shown in percent and
were compared to the GIII dsRNA-injected control ticks by χ
2 test (*α<0.01). Tick weight and oviposition (eggs per tick) are shown as average ±
SD and were compared to the GIII dsRNA-injected control ticks by Student's t test (**P<0.05; ***P<0.01)
UNI uninjected
Parasitol Res (2010) 106:471–479 475increase immunogenicity (Rodríguez et al. 1994; Haro and
Gómara 2004). In cattle immunized with recombinant SUB,
antibody titers increased after the first immunization and
then decreased after the second immunization (Fig. 1). The
cause for this decrease in anti-SUB antibody titers after the
second immunization is unknown but could be due to
problems associated with the stability of the vaccine
formulation. The vaccine containing the recombinant
Bm86 antigen in Montanide ISA 50 V has been shown to
be stable even at field temperature (Canales et al. 2007 and
unpublished results), but vaccine stability could be different
for different antigen preparations. In general, antibody titers
were low in immunized cattle, even in the animals
vaccinated with the control Bm86 vaccine when compared
to previous studies (Canales et al. 2009a). Although cattle
were apparently healthy, low antibody responses after
vaccination suggested that animals were probably not in
the best health condition. Nevertheless, a positive correla-
tion (correlation coefficients R
2=0.7, 0.8, and 0.9 in UBQ-,
SUB-, and Bm86-immunized cattle, respectively) between
antibody titers 1 week after tick infestation and vaccine
efficacy calculated in individual cattle was obtained for
R. microplus. For R. annulatus, a positive correlation (R
2=
0.6) between antibody titers and vaccine efficacy was
obtained in SUB-immunized cattle only. A positive corre-
lation between antibody titers and vaccine efficacy has been
previously demonstrated in Bm86-vaccinated cattle and
underlines the effect of antitick vaccines on the control of
cattle tick infestations (Cobon et al. 1995; de la Fuente
et al. 1998).
The results of the vaccine trial showed an effect on
R. microplus and R. annulatus infestations for all three
antigens when compared to controls (Tables 3 and 4). The
efficacy with the Bm86 vaccine were within the range
reported in previous experiments (Cobon et al. 1995;
Fragoso et al. 1998; de la Fuente et al. 1998, 1999,
2000a, b; García-García et al. 2000; de Vos et al. 2001;d e
la Fuente and Kocan 2003, 2006; Canales et al. 2009a) and
was higher than that obtained with UBQ and SUB vaccines
Tick infestation
Fig. 1 Antibody response in vaccinated cattle. Bovine serum
antibody titers to recombinant antigens were determined by ELISA
in cattle vaccinated with ubiquitin, subolesin, Bm86, and adjuvant/
saline control. Antibody titers in immunized cattle were expressed as
the OD450 nm value for the highest serum dilution (1:1,000) and
compared between vaccinated and control cattle using an ANOVA test
(*P<0.05). The time of vaccination shots (arrows) and tick infestation
are indicated
Table 3 Control of R. microplus infestations in cattle vaccinated with the recombinant antigens
R. microplus (susceptible; Mexico strain)
Percent reduction (vaccinated/control)
b E
c
Experimental group
a DT DW DO DF
Ubiquitin 26% 9% –2% 29% 55%
(1,079±410) (251±52) (109±9) (0.37±0.04)
Subolesin 43% 0% 0% 15% 51%
(835±179)* (277±33) (107±21) (0.44±0.06)
Bm86 51% 5% 14% 6% 60%
(714±208)* (261±26) (92±16) (0.49±0.04)
Adjuvant/saline control (1,454±206) (276±14) (107±12) (0.52±0.29) –
DT percentage reduction in tick infestation, DW percentage reduction in tick weight, DO percentage reduction in oviposition, DF percentage
reduction in egg fertility
aCattle were randomly assigned to experimental groups (N=4), vaccinated, and challenged with R. microplus and R. annulatus larvae
bThe percent reduction was calculated with respect to the control group. In parenthesis are shown the average ± SD for adult female tick number,
tick weight (milligram), oviposition (egg weight (milligram) per tick), and egg fertility (larvae weight per egg weight) and were compared by
Student's t test with unequal variance between vaccinated and control groups (*P<0.05)
cVaccine efficacy (E) was calculated as 100 l   CRT   CR0   CRF ðÞ ½  , where CRT, CRO, and CRF are the reduction in the number of adult
female ticks, oviposition, and egg fertility as compared to the control group, respectively
476 Parasitol Res (2010) 106:471–479in both tick species. Particularly for R. annulatus control, it
is difficult to improve the results obtained with Bm86
vaccines which attain >99% efficacy in all experiments
(Fragoso et al. 1998; de la Fuente et al. 2000a, b; de Vos et
al. 2001; Canales et al. 2009a). For SUB, this is the first
vaccination trial in R. microplus and R. annulatus, and the
results were similar to those reported in other tick species
(Almazán et al. 2005a, b; de la Fuente et al. 2006; Canales
et al. 2009b) and support further experiments with this
antigen. Vaccination with the UBQ peptide had some
efficacy on tick control, particularly on R. microplus
infestations (Table 3). However, these results were affected
by the low immunogenicity of the UBQ vaccine preparation
and require additional trials with improved peptide for-
mulations before a conclusion could be reached.
The genes were selected for vaccination trials based on
their effect on tick mortality and fertility after RNAi
experiments included those encoding for proteins involved
in the regulation of mRNA and protein synthesis and
metabolism with potential impact on important biological
processes in eukaryotes such as cell growth and mainte-
nance. However, these proteins are cytoplasmic and may be
evolutionary highly conserved which may pose a problem
for their use in vaccine formulations for the control of tick
infestations. As previously discussed, the conservation of
protein ortholog sequences among arthropod vectors and
vertebrate hosts may raise the question of safety when using
them for immunization with the potential of inducing
autoimmune responses damaging to the host (Canales et
al. 2009b). However, it is expected that the antibody
response would be primarily directed against nonself
epitopes thus reducing the possibility of detrimental effects
to the host. Additionally, immunization with intracellular
proteins has been effective in ticks and other invertebrate
organisms and suggests a low risk to induce autoimmune
responses in vertebrate hosts (Elad and Segal 1995;
Almazán et al. 2005a, b; de la Fuente et al. 2006; Canales
et al. 2009b).
In summary, these experiments showed that RNAi could
be used for the selection of candidate tick-protective
antigens. However, vaccination trials are necessary to
evaluate the effect of recombinant antigens in the control
of tick infestations, a process that requires efficient
recombinant protein production and formulation systems.
The results with the SUB vaccine encourage further
investigations on the use of recombinant subolesin alone
or in combination with other antigens for the control of
cattle tick infestations.
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Table 4 Control of R. annulatus infestations in cattle vaccinated with the recombinant antigens
R. annulatus (Mission, TX strain)
Percent reduction (vaccinated/control)
b E
c
Experimental group
a DT DW DO DF
Ubiquitin −2% −19% −21% 15% 15%
(519±96) (275±29) (109±15) (0.13±0.03)
Subolesin 18% 17% 23% 37% 60%
(419±288) (192±129) (69±49) (0.09±0.07)
Bm86 100% All ticks All ticks All ticks 100%
(0±0)* Died Died Died
Adjuvant/saline control (509±145) (231±28) (90±20) (0.15±0.03) –
DT percentage reduction in tick infestation, DW percentage reduction in tick weight, DO percentage reduction in oviposition, DF percentage
reduction in egg fertility
aCattle were randomly assigned to experimental groups (N=4), vaccinated, and challenged with R. microplus and R. annulatus larvae
bThe percent reduction was calculated with respect to the control group. In parenthesis are shown the average ± SD for adult female tick number,
tick weight (milligram), oviposition (egg weight (milligram) per tick) and egg fertility (larvae weight per egg weight) and were compared by
Student's t test with unequal variance between vaccinated and control groups (*P<0.05)
cVaccine efficacy (E) was calculated as 100 l   CRT   CR0   CRF ðÞ ½  , where CRT, CRO, and CRF are the reduction in the number of adult
female ticks, oviposition, and egg fertility as compared to the control group, respectively
Parasitol Res (2010) 106:471–479 477Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
Almazán C, Blas-Machado U, Kocan KM, Yoshioka JH, Blouin EF,
Mangold AJ, de la Fuente J (2005a) Characterization of three
Ixodes scapularis cDNAs protective against tick infestations.
Vaccine 23:4403–4416
Almazán C, Kocan KM, Blouin EF, de la Fuente J (2005b)
Vaccination with recombinant tick antigens for the control of
Ixodes scapularis adult infestations. Vaccine 23:5294–5298
Barker SC, Murrell A (2004) Systematics and evolution of ticks
with a list of valid genus and species names. Parasitol 129:S15–
S36
Canales M, Enriquez A, Ramos E, Cabrera D, Dandie H, Soto A,
Falcon V, Rodríguez M, de la Fuente J (1997) Large-scale
production in Pichia pastoris of the recombinant vaccine
Gavac™ against cattle ticks. Vaccine 15:414–422
Canales M, Pérez de la Lastra JM, Naranjo V, Nijhof AM, Hope M,
Jongejan F, de la Fuente J (2008) Expression of recombinant
Rhipicephalus (Boophilus) microplus, R. annulatus and R.
decoloratus Bm86 orthologs as secreted proteins in Pichia
pastoris. BMC Biotechnol 8:14
Canales M, Almazán C, Naranjo V, Jongejan F, de la Fuente J (2009a)
Vaccination with recombinant Boophilus annulatus Bm86 ortholog
protein, Ba86, protects cattle against B. annulatus and B. microplus
infestations. BMC Biotechnol 9:29
Canales M, Naranjo V, Almazán C, Molina R, Tsuruta SA, Szabó
MPJ, Manzano-Roman R, Pérez de la Lastra JM, Kocan KM,
Jiménez MI, Lucientes J, Villar M, de la Fuente J (2009b)
Conservation and immunogenicity of the mosquito ortholog of
the tick protective antigen, subolesin. Parasitol Res 105:97–111
Cobon G, Hungerford J, Woodrow M, Smith D, Willadsen P (1995)
Vaccination against Boophilus microplus. The Australian field
experience. In: de la Fuente J (ed) Recombinant vaccines for the
control of cattle tick. Elfos Scientiae, La Habana, Cuba, pp 163–
176
de la Fuente J, Kocan KM (2003) Advances in the identification and
characterization of protective antigens for development of
recombinant vaccines against tick infestations. Expert Rev
Vaccines 2:583–593
de la Fuente J, Kocan KM (2006) Strategies for development of
vaccines for control of ixodid tick species. Parasite Immunol
28:275–283
de la Fuente J, Rodríguez M, Redondo M, Montero C, García-García
JC, Méndez L, Serrano E, Valdés M, Enríquez A, Canales M,
Ramos E, de Armas CA, Rey S, Rodríguez JL, Artiles M, García
L (1998) Field studies and cost-effectiveness analysis of
vaccination with Gavac™ against the cattle tick Boophilus
microplus. Vaccine 16:366–373
de la Fuente J, Rodríguez M, Montero C, Redondo M, García-García
JC, Méndez L, Serrano E, Valdés M, Enríquez A, Canales M,
Ramos E, Boué O, Machado H, Lleonart R (1999) Vaccination
against ticks (Boophilus spp.): the experience with the Bm86-based
vaccine Gavac™. Genetic Analysis: Biomolecular Engineering
15:143–148
de la Fuente J, Rodríguez M, Garcia-Garcia JC (2000a) Immunological
control of ticks through vaccination with Boophilus microplus gut
antigens. Ann NY Acad Sci 916:617–621
de la Fuente J, García-García JC, González DM, Izquierdo G,
Ochagavia ME (2000b) Molecular analysis of Boophilus spp.
(Acari: Ixodidae) tick strains. Vet Parasitol 92:209–222
de la Fuente J, Almazán C, Blouin EF, Naranjo V, Kocan KM (2005)
RNA interference screening in ticks for identification of
protective antigens. Parasitol Res 96:137–141
de la Fuente J, Almazán C, Blas-Machado U, Naranjo V, Mangold AJ,
Blouin EF, Gortazar C, Kocan KM (2006) The tick protective
antigen, 4D8, is a conserved protein involved in modulation of
tick blood ingestion and reproduction. Vaccine 24:4082–4095
de la Fuente J, Almazán C, Canales M, Pérez de la Lastra JM, Kocan
KM, Willadsen P (2007a) A ten-year review of commercial
vaccine performance for control of tick infestations on cattle.
Anim Health Res Rev 8:23–28
de la Fuente J, Blouin EF, Manzano-Roman R, Naranjo V, Almazán C,
Perez de la Lastra JM, Zivkovic Z, Jongejan F, Kocan KM
(2007b) Functional genomic studies of tick cells in response to
infection with the cattle pathogen, Anaplasma marginale.
Genomics 90:712–722
de la Fuente J, Kocan KM, Almazán C, Blouin EF (2007c) RNA
interference for the study and genetic manipulation of ticks.
Trends Parasitol 23:427–433
de la Fuente J, Maritz-Olivier C, Naranjo V, Ayoubi P, Nijhof AM,
Almazán C, Canales M, Pérez de la Lastra JM, Galindo RC,
Blouin EF, Gortazar C, Jongejan F, Kocan KM (2008) Evidence
of the role of tick subolesin in gene expression. BMC Genomics
9:372
de Vos S, Zeinstra L, Taoufik O, Willadsen P, Jongejan F (2001)
Evidence for the utility of the Bm86 antigen from Boophilus
microplus in vaccination against other tick species. Exp Appl
Acarol 25:245–261
Elad D, Segal E (1995) Immunogenicity in calves of a crude
ribosomal fraction of Trichophyton verrucosum: a field trial.
Vaccine 13:83–87
Estrada-Peña A, Bouattour A, Camicas JL, Guglielmone A, Horak I,
Jongejan F, Latif A, Pegram R, Walker AR (2006) The known
distribution and ecological preferences of the tick subgenus
Boophilus (Acari: Ixodidae) in Africa and Latin America. Exp
Appl Acarol 38:219–235
Fragoso H, Hoshmand Rad P, Ortiz M, Rodríguez M, Redondo M,
Herrera L, de la Fuente J (1998) Protection against Boophilus
annulatus infestations in cattle vaccinated with the B. microplus
Bm86-containing vaccine Gavac. Vaccine 16:1990–1992
García-García JC, González IL, González DM, Valdés M, Méndez L,
Lamberti J, D’Agostino B, Citroni D, Fragoso H, Ortiz M,
Rodríguez M, de la Fuente J (1999) Sequence variations in the
Boophilus microplus Bm86 locus and implications for immuno-
protection in cattle vaccinated with this antigen. Exp Appl Acarol
23:883–895
García-García JC, Montero C, Redondo M, Vargas M, Canales M,
Boué O, Rodríguez M, Joglar M, Machado H, González IL,
Valdés M, Méndez L, de la Fuente J (2000) Control of ticks
resistant to immunization with Bm86 in cattle vaccinated with the
recombinant antigen Bm95 isolated from the cattle tick,
Boophilus microplus. Vaccine 18:2275–2287
Graf JF, Gogolewski R, Leach-Bing N, Sabatini GA, Molento MB,
Bordin EL, Arantes GJ (2004) Tick control: an industry point of
view. Parasitol 129:S427–S442
Haro I, Gómara MJ (2004) Design of synthetic peptidic constructs for
the vaccine development against viral infections. Curr Protein
Pept Sci 5:425–433
Nijhof AM, Taoufik A, de la Fuente J, Kocan KM, de Vries E,
Jongejan F (2007) Gene silencing of the tick protective antigens,
Bm86, Bm91 and subolesin, in the one-host tick Boophilus
microplus by RNA interference. Int J Parasitol 37:653–662
478 Parasitol Res (2010) 106:471–479Olwoch JM, Van Jaarsveld AS, Scholtz CH, Horak IG (2007) Climate
change and the genus Rhipicephalus (Acari: Ixodidae) in Africa.
Onderstepoort J Vet Res 74:45–72
Peter RJ, Van den Bossche P, Penzhorn BL, Sharp B (2005) Tick, fly,
and mosquito control—lessons from the past, solutions for the
future. Vet Parasitol 132:205–215
Rand KN, Moore T, Sriskantha A, Spring K, Tellam R, Willadsen P,
Cobon G (1989) Cloning and expression of a protective antigen
from the cattle tick Boophilus microplus. Proc Natl Acad Sci
USA 86:9657–9661
Rodríguez M, Rubiera R, Montesinos R, Cremata JA, Falcón V,
Sanchez G, Bringas R, Cordovés C, Valdés M, Lleonart R,
Herrera L, de la Fuente J (1994) High level expression of the B.
microplus Bm86 antigen in the yeast P. pastoris forming highly
immunogenic particles for cattle. J Biotechnol 33:135–146
Rodríguez Valle M, Méndez L, Valdez M, Redondo M, Espinosa CM,
Vargas M, Cruz RL, Barrios HP, Seoane G, Ramírez ES, Boué O,
Vigil JL, Machado H, Nordelo CB, Piñeiro MJ (2004) Integrated
control of Boophilus microplus ticks in Cuba based on
vaccination with the anti-tick vaccine Gavac. Exp Appl Acarol
34:375–382
Sonenshine DE, Kocan KM, de la Fuente J (2006) Tick control: further
thoughts on a research agenda. Trends Parasitol 22:550–551
Sossai S, Peconick AP, Sales-Junior PA, Marcelino FC, Vargas MI,
Neves ES, Patarroyo JH (2005) Polymorphism of the bm86 gene
in South American strains of the cattle tick Boophilus microplus.
Exp Appl Acarol 37:199–214
Willadsen P (2006) Tick control: thoughts on a research agenda. Vet
Parasitol 138:161–168
Willadsen P, Riding GA, McKenna RV, Kemp DH, Tellam RL,
Nielsen JN, Lahstein J, Cobon GS, Gough JM (1989) Immuno-
logical control of a parasitic arthropod: identification of a
protective antigen from Boophilus microplus. J Immunol
143:1346–1351
Parasitol Res (2010) 106:471–479 479